-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
US health chief based vaccine cuts on misinformation, researchers say
US Health Secretary Robert F. Kennedy Jr. cited false claims to justify terminating 22 federal contracts for mRNA-based vaccines, researchers said Friday, a day after the World Health Organization called the decision a major blow.
Kennedy on Tuesday announced the cancellation of contracts worth around $500 million, marking his latest attempt to infuse vaccine skepticism into the core of US health policy.
Citing medical experts, disinformation watchdog NewsGuard identified a series of false claims about the vaccines –- credited with saving millions of lives during the Covid-19 pandemic -- that Kennedy promoted to explain the termination.
Kennedy claimed that mRNA vaccines were responsible for "new mutations" of the virus, thus creating new variants that can prolong pandemics.
"Kennedy is mistaken in statements made when ceasing funding for mRNA vaccine development," Stephen Evans, a professor at the London School of Hygiene and Tropical Medicine, told the London-based Science Media Centre.
"No vaccine, including mRNA encourages new mutations."
Kennedy also made two previously debunked claims about the effectiveness of the vaccines.
He stated that mRNA vaccines "fail to protect effectively against upper respiratory infections like Covid" and added that mRNA technology "poses more risks than benefits."
Evans said the vaccines were "extremely effective against Covid, preventing deaths, hospitalisations and clinical or sub-clinical infection."
"No vaccine has a zero incidence of side-effects, some of which can be serious, but the benefits of both mRNA vaccines and other types of vaccine –- lives saved and illness reduced -- hugely outweigh the risks," Charles Bangham, a professor of immunology at the Imperial College London, told the Science Media Centre.
On Thursday, WHO immunisation figurehead Joachim Hombach called the US decision to terminate the contracts a "significant blow."
"mRNA vaccines are a very important technology and platform which has served us extremely well for Covid. We also know there is very promising work going on in relation to influenza vaccines," he said.
Echoing those comments, US experts have warned that the funding cuts threaten critical research and public health around the world.
"This sets back vaccine science by a decade," Andrew Pekosz, a professor of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health, wrote on X.
"Of course they didn't read the science or listen to the experts... if they did, they wouldn't have made this decision."
Kennedy, who spent two decades sowing misinformation around immunization, has overseen a major overhaul of US health policy since taking office.
He has fired, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees.
In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record.
He has also ordered a sweeping new study on the long-debunked link between vaccines and autism.
burs-ac/bgs
Y.Nakamura--AMWN